Reimbursement Knowledge Guide for Medical Devices

This guide serves as a resource for understanding the reimbursement landscape for medical devices, detailing the complexities involved in securing coverage from health insurers. It explains how coverage decisions are made for various medical devices, including those that are usually covered, such as diabetic glucose monitoring devices, and those that typically are not covered, including most non-FDA approved devices. The guide outlines the critical factors influencing the success of new devices in the marketplace, particularly regarding the evidence required to persuade payers and the importance of articulating the value proposition of new technologies. Additionally, it describes the development of a reimbursement strategy, emphasizing that this process should begin early in the development timeline, ideally prior to obtaining FDA clearance. The guide also includes case studies that provide in-depth discussion on managing tasks related to research, clinical trials, regulations, and post-market surveillance. Topics covered include the roles of Medicare, Medicaid, and commercial payers in evaluating new devices, along with coding and payment considerations.